• Gastroretentive Alfuzosin HCl Sponges: MRI Evaluation and De

  2026-07-09

  This study pioneers the development of low-density, gastroretentive sponges for sustained delivery of Alfuzosin HCl using chitosan and HPMC matrices, validated in healthy volunteers by MRI. The findings offer an advanced oral formulation approach to improve bioavailability and targeted release for benign prostatic hyperplasia research.

• RG108: DNA Methyltransferase Inhibitor for Epigenetic Modula

  2026-07-08

  RG108 stands out as a non-nucleosidic DNA methyltransferase inhibitor, enabling precise demethylation and reactivation of silenced tumor suppressor genes without covalent enzyme trapping. Its unique profile makes it a key tool for cancer research and advanced epigenetic workflows, with proven performance in human cell line models.

• GPX4-Mediated Glutathione Use Drives Platinum Resistance in

  2026-07-08

  This study identifies glutathione peroxidase 4 (GPX4)-dependent glutathione consumption as a central mechanism of platinum chemoresistance in lung cancer-derived brain metastases. By uncovering a regulatory Wnt/NR2F2/GPX4 axis that suppresses ferroptosis, the research reveals new intervention points for overcoming resistance and refining experimental strategies in cancer biology.

• BMX-IN-1: Applied BMX Kinase Inhibitor Workflows & Optimizat

  2026-07-07

  BMX-IN-1 unlocks precise control over BMX kinase signaling, empowering advanced studies in cancer biology and host-pathogen interactions. This guide translates the latest BMX kinase research breakthroughs into actionable protocols, troubleshooting advice, and comparative insights for accelerating data-driven discoveries.

• Cardiogreen (Indocyanine Green): Clinical Mechanisms & Evide

  2026-07-07

  Cardiogreen, also known as Indocyanine Green, is a nontoxic, near-infrared dye crucial in cardiac output, liver blood flow, and ophthalmic angiography. Its rapid plasma binding and vascular confinement enable high-sensitivity diagnostics and efficient apoptosis induction in photodynamic therapy, as validated by clinical and laboratory evidence.

• Clodronate Liposomes: Unraveling Macrophage Roles in Tumor I

  2026-07-06

  Explore how Clodronate Liposomes empower precise in vivo macrophage depletion to dissect tumor immunology, with unique insights into immunotherapy resistance mechanisms. This article integrates mechanistic detail, protocol guidance, and recent advances for translational research.

• Neutrophil Extracellular Traps in CML: Effects of Kinase Inh

  2026-07-06

  This study demonstrates that NET formation is markedly increased in chronic myeloid leukemia and that tyrosine kinase inhibitors can differentially modulate this process. These findings provide mechanistic insight into potential links between kinase inhibition, thrombosis, and vascular toxicity in CML research.

• SmD2 Acetylation and HDAC2 Inhibition Sensitize HCC to PARPi

  2026-07-05

  This study reveals that acetylation-dependent regulation of the spliceosome core component SmD2 critically influences DNA repair and alternative splicing in hepatocellular carcinoma (HCC). Targeting HDAC2-mediated deacetylation of SmD2 with Romidepsin enhances HCC cell sensitivity to PARP inhibitors, suggesting a novel combinatorial therapeutic strategy.

• Risedronate Sodium: FPP Synthase Inhibitor in Bone & Lung Re

  2026-07-04

  Risedronate Sodium acts as a potent FPP synthase inhibitor, suppressing osteoclast-mediated bone resorption and inducing apoptosis in alveolar macrophages. Its advanced delivery systems, such as inhalable microspheres, improve bioavailability and therapeutic targeting for osteoporosis and pulmonary emphysema. APExBIO provides rigorously characterized Risedronate Sodium for research and clinical translation.

• MDV3100 (Enzalutamide): Dissecting AR Heterogeneity in Prost

  2026-07-03

  Explore how MDV3100 (Enzalutamide) enables advanced dissection of androgen receptor heterogeneity and resistance in prostate cancer research. This article offers a practical, evidence-based guide distinct from existing resources.

• Disabling Tumor Extracellular Vesicles to Inhibit Metastasis

  2026-07-03

  The referenced Nature Cancer study presents a lipidated nanophotosensitizer that actively traces and disables tumor extracellular vesicles (TEVs), simultaneously suppressing tumor growth and metastasis in murine models. This dual-function approach offers new opportunities for more selective and effective antimetastatic strategies by targeting TEV-mediated intercellular communication.

• Lypressin Acetate: Applied Protocols for Vasopressor and Ant

  2026-07-02

  Lypressin acetate stands at the intersection of classic antidiuretic studies and emerging antiviral research, offering unmatched precision and reproducibility for GPCR-driven workflows. This guide translates recent structural and pharmacodynamic insights into actionable protocols and troubleshooting strategies for fluid homeostasis, vasoconstriction, and SARS-CoV-2 RdRp inhibition studies.

• GSK J4 HCl: Epigenetic Precision for Immune and Inflammatory

  2026-07-02

  Explore how GSK J4 HCl, a potent JMJD3 inhibitor, is uniquely positioned for advanced epigenetic regulation research. This deep-dive reveals insights into immune modulation, practical assay nuances, and emerging therapeutic frontiers.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone): P

  2026-07-01

  Unlock the full analytical power of FCCP as a mitochondrial uncoupler for metabolic regulation and hypoxia pathway research. This guide translates new mechanistic insights into actionable workflows, troubleshooting strategies, and comparative advantages for advanced cell biology experiments.

• Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici

  2026-07-01

  This study demonstrates that dual inhibition of AMPA and NMDA receptors with IEM-1925 provides robust antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. The findings clarify the mechanistic value of targeting glutamatergic signaling to counteract organophosphorus nerve agent–induced brain injury and suggest key parameters for translational neuroprotection assays.

3584 records 8/239 page Previous Next First page 上5页 678910 下5页 Last page